Could a hip operation sideline him for months? The Astros confirmed that outfielder Joey Loperfido underwent arthroscopic surgery to treat an impingement and labral tear in his right hip. No recovery timetable was given, and the club warned his spring‑training debut will be pushed back. MLB.com’s Brian McTaggart relayed the news.
That news came out of left field. Loperfido had landed on the injured list early in 2026 with a quad strain, and doctors later uncovered the hip problem shortly after the season wrapped, prompting the procedure.
Heading into 2027, Loperfido finds himself in a tricky spot. Houston added him to the 40‑man roster in April 2024, shuffled him between Triple‑A and the majors, then dealt him to Toronto at the deadline. He repeated the back‑and‑forth role with the Blue Jays through 2025 before returning to Houston for 2026 in exchange for Jesús Sánchez. Now his three option years are used up, leaving him without options for next season.
Overall, his big‑league production has been merely adequate. Over the past three seasons he logged 487 plate appearances, posting a 6.4% walk rate and a 31.6% strikeout rate—both slightly below league average. His .240/.300/.378 line translates to a 92 wRC+, about eight percent under average, buoyed by a .345 BABIP, more than 50 points above the norm.
Defensively, Loperfido has covered all three outfield spots, primarily patrolling left field. In 702 innings there, he recorded eight Defensive Runs Saved, two Outs Above Average, and earned a Fielding Run Value grade of two. His metrics in center and right were somewhat sub‑par.
Houston’s outfield remains wide open. Cam Smith is entrenched in right, while Yordan Alvarez will pop into left occasionally but mainly serve as DH. The roster also lists Jake Meyers, Taylor Trammell, Lucas Spence, Brice Matthews, Zach Cole, Zach Dezenzo, Jorge Barrosa and Nelson Velázquez, none of whom have a guaranteed role for next year.
Meyers and Trammell face arbitration and could be non‑tendered. Barrosa was outrighted in September, only to return when Daulton Varsho went down. Spence ended the year hot but has just 63 big‑league PA with a 34.9% strikeout rate. Matthews, Dezenzo and Cole have yet to make a mark, and Velázquez remains a platoon left‑handed bat.
While his major‑league totals are modest, Loperfido excelled in the minors from 2024‑2026, posting a 9.7% walk rate, 23% strikeout rate, and a .273/.359/.434 slash line with 112 wRC+. Coupled with acceptable defense across the outfield, he could serve as a useful bench piece. For my money, his cheap, pre‑arbitration contract makes him an attractive depth option for a club wary of the competitive‑balance tax.
At 27, he still hasn’t broken through, and losing his options adds pressure to stick on a roster. He’ll miss the offseason IL, so his health won’t be monitored. Add those factors together, and his spot looks increasingly tenuous. Will he secure a roster slot once his options are gone?